Back to 
Moneta Group Investment Advisors LLC
Moneta Group Investment Advisors LLC
ARWR
Showing 0 of 14 quarters
Position history for Moneta Group Investment Advisors LLC's holdings in Arrowhead Pharmaceuticals, Inc.
No. Moneta Group Investment Advisors exited its ARWR (Arrowhead Pharmaceuticals) position in Q3 2022. Its Q2 2022 13F listed 7,981 shares worth $281,000. Moneta Group Investment Advisors first reported ARWR in Q2 2019 and held it in 13 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.